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Abstract
Background: The influence of the gut flora on lung inflammatory reaction against bacterial challenge remains
undefined. This study was designed to investigate whether gut flora enhances lung defense against E.coli
pneumonia through TLR4 signaling.
Methods: C3H/HeN (WT) mice and C3H/HeJ (TLR4 deficient) mice were treated with antibiotics in drinking water
for 4 weeks to deplete gut commensal microflora. At week 3, drinking water was supplemented with
lipopolysaccharide (LPS); a ligand for TLR4, to trigger TLRs in intestinal tract. At the end of 4th week, E.coli was
injected to trachea to induce E.coli pneumonia.
Results: We found that commensal depletion by antibiotic pretreatment before E.coli pneumonia challenge
induced a 30% decrease of MPO activity in the lung, a significant decrease of bacterial killing activity of alveolar
macrophage, and bacterial counts in C3H/HeN mice but not in C3H/HeJ (TLR4 deficient) mice. LPS, a TLR4 ligand,
supplementation during antibiotic pretreatment reversed these effects and decreased E.coli pneumonia-induced
mortality in C3H/HeN mice. Furthermore, commensal depletion induced a suppression of NF-B DNA binding
activity and an increase of KC, MIP-2, IL-1b expression in the lung in C3H/HeN mice but not in C3H/HeJ mice.
Conclusions: Taken together with that commensal depletion increased E.coli pneumonia-induced mortality and
LPS supplementation decreased it, we conclude that gut flora enhances bacterial clearance against E.coli
pneumonia through TLR4.
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Background
Lower respiratory infections account for nearly 35% of
all deaths from infectious disease. Despite the develop-
ment of broad-spectrum antibiotics, lower respiratory
bacterial infections continue to be a major cause of
mortality in both industrialized and developing countries
[1,2]. Increased mortality during bacterial pneumonia
may have resulted from a failure to control bacterial
growth in the lung or to prevent inflammatory injury to
the lung. The influence of the gut-lung axis on lung
injury and immunity has been known for years, yet the
underlying mechanism is not completely understood [3].
It has previously been shown that protecting the integ-
rity of the gut mucosa was effective in reducing idio-
pathic pneumonia syndrome [3]. Furthermore, clinical
trials have demonstrated that enteral feedings signifi-
cantly reduced the incidence of pneumonia compared to
patients fed parenterally [4]. Clearly defining the role of
commensal microflora in lung inflammation against
pneumonia is warranted to characterize the link
between the gut and respiratory tract.
An acute innate immune response in the lung has
been characterized by the infiltration of neutrophils [5].
An insufficient neutrophils recruitment leads to life-
threatening infection despite the fact that an extreme
accumulation of neutrophils results in excessive lung
injury association with inflammation. Furthermore, lung
content of myeloperoxidase (MPO) is an index to assess
the degree of pulmonary neutrophils infiltration. MPO,
released by neutrophils, may attack normal tissue and
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thus contribute to the pathogenesis disease. A better
understanding of the mechanisms underlying the regula-
tion of neutrophils influx is crucial to designing
improved therapies to augment host defense and attenu-
ate detrimental lung inflammation.
The innate immune system detects the invasion of
microorganism through TLRs, which recognize micro-
bial components and trigger inflammatory responses [6].
TLRs are germ line-encoded pattern recognition recep-
tors, and more than 11 members have been identified.
Different bacterial products, such as lipopolysaccharide
(LPS) and lipoteichoic acid (LTA), were recognized by
TLR4 and TLR2, respectively [7]. Previous work has
shown that activation of TLRs by LPS administration via
the oral route completely protected animals from the
dextran sulphate sodium (DSS)-induced inflammatory
mortality, morbidity, and severe colonic bleeding seen in
mice with depletion of commensal microflora [8]. Also,
recent findings suggest that TLR4 plays a critical role in
mediating an effective innate immune response against
H. influenzae in the lung [9]. A major downstream effect
of TLR signaling is the activation of the transcription
factor NF-B, which is required for expression of many
genes related to innate immunity and inflammation [10].
Previous studies have shown that inflammatory signaling
through the NF-B pathway in airway epithelial cells is
critical to regulating the innate immune response
against P. aeruginosa [11]. Elucidating the key molecules
involved with innate pulmonary defense upon recogni-
tion of bacteria by pattern recognition receptors are for-
midable tasks.
Commensal microflora in the intestinal tract could
play an important role in the inflammatory reaction of
lung against bacterial challenge. The aim of this study is
to investigate the role of gut flora in E.coli pneumonia-
induced lung inflammation. We hypothesized that com-
mensal microflora in the gut could increase lung inflam-
matory reaction through the toll-like receptors 4
(TLR4). We studied the effect of commensal depletion
on E.coli pneumonia-induced MPO activity in the lung
and the killing activity of alveolar macrophages. Using a
commensal depletion model in WT and TLR4 mutant
mice, we demonstrate that gut flora are involved in
inducing lung inflammatory reaction against bacterial
challenge through toll-like receptor 4. Adding TLR
ligands in drinking water could be a promising thera-
peutic strategy to enhance inflammatory reaction against
pneumonia in immunocompromised patients.
Methods
Animals
Specific pathogen-free male C3H/HeN, weighing
between 20 and 25 g were obtained from the National
Laboratory Breeding and Research Center (NLBRC,
Taipei, Taiwan). C3H/HeJ (TLR4 mutant) mice were
purchased from the Jackson Laboratory (Bar Harbor,
ME) and bred in the animal room of National Sun Yat-
Sen University. C3H/HeJ mice have been demonstrated
to have a missense mutation in the third exon of TLR4,
yielding a nonfunctional TLR4 [12]. They were fed stan-
dard laboratory chow and water ad libitum in the ani-
mal facility. All animal procedures were in compliance
with regulations on animal used for experimental and
other scientific purposes approved by the National Sun
Yat-Sen University Animal Experiments Committee.
Depletion of gut commensal microflora and
reconstitution of commensal-depleted animals with TLR
ligands
Animals are provided ampicillin (A; 1 g/L; Sigma), van-
comycin (V; 500 mg/L; Abott Labs), neomycin sulfate
(N: 1 g/L; Pharmacia/Upjohn), and metronidazole (M; 1
g/L; Sidmack Labs) in drinking water for four weeks.
Previously, a four-week oral administration of vancomy-
cin, neomycin, metronidazole, and ampicillin with the
same dose described above in mice has been proved to
deplete all detectable commensals [8]. To those animals
receiving TLR ligands, drinking water is supplemented
with 10 μg/μl of purified E.coli 026:B6 LPS (Sigma) at
week 3 and continued in drinking water for the duration
of E.coli pneumonia. LPS, a membrane constituent of
Gram-negative bacteria, is the best-studied TLR ligand
and is recognized by TLR4 and MD-2, a molecule asso-
ciated with the extracellular domain of TLR4.
Experimental Design
Experiment 1
To examine the role of TLR4 on E.coli pneumonia-
induced lung inflammatory reaction, C3H/HeN and
C3H/HeJ mice were divided into four groups each.
Group I (E.coli group, n = 6), received E.coli intratra-
cheal injection; Group II (LPS + E.coli group, n = 6),
received LPS supplementation in drinking water for one
week and E.coli injection; Group III (antibiotic + E.coli
group, n = 6), received oral antibiotic for four weeks
and E.coli injection at the end of fourth week. Group IV
(antibiotic + LPS + E.coli group, n = 6), received oral
antibiotic with LPS supplementation and E.coli intratra-
cheal injection. At 18 hr after E.coli intratracheal injec-
tion, animals were sacrificed, lung were harvested for
MPO activity assay. At 8 hr after E.coli intratracheal
injection, lung were harvested for NF-B DNA-binding
activity; IL-1b protein as well as IL-1b, KC, and MIP-2
mRNA expression.
Experiment 2
To examine the role of TLR4 in bacterial killing activity
of alveolar macrophage, C3H/HeN and C3H/HeJ mice
were randomly divided into four groups. Group I
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(control group, n = 6); Group II (LPS group, n = 6),
received LPS supplementation in drinking water for one
week; Group III (antibiotic group, n = 6), received oral
antibiotic for four weeks; Group IV (antibiotic + LPS
group, n = 6), received oral antibiotic with LPS supple-
mentation at week 3. At the end of the 4th week, alveo-
lar macrophages of animals were harvested for the
bacterial killing activity assay.
Experiment 3
To examine the role of commensal microflora on E.coli
pneumonia-induced mortality, C3H/HeN were divided
into three groups. Group I, received E.coli intratracheal
injection; Group II, received oral antibiotic for four
weeks and E.coli intratracheal injection. Group III (anti-
biotic + LPS + E.coli group), received oral antibiotic
with LPS supplementation and E.coli intratracheal injec-
tion. Animals were monitored for mortality after E.coli
injection for 96 hours.
Induction of pneumonia
Mice were anesthetized with ketamine hydrochloride
(100 mg/kg intramuscularly, Veterinary Laboratories,
Wyeth-Ayerst Canada Inc., Mississauga, ON, Canada)
and xylazine (5 mg/kg intramuscularly, Bayer Inc., Mis-
sissauga, ON, Canada). We have conducted a dose-
dependence study with 1.0 × 109 CFU being the highest
dose and found that less dose did not cause pulmonary
sepsis and lethality in normal immunocompetent mice.
Also, previous paper suggested that intratracheal injec-
tion of 1.0 × 109 CFU E.coli could induce significant
pneumonia [13]. Therefore, the trachea was surgically
exposed and 50 μl (1.0 × 109 CFU E.coli) were instilled
via an angiocatheter through the trachea as previous
paper suggested [13]. Concentrations of Escherichia coli
(strain 19138; American Type Culture Collection, Mana-
ssas, VA) were determined by colony counting.
Determination of lung myeloperoxidase activity
Mice were anesthetized and the thorax was opened with
median sternotomy. The bilateral lungs and heart were
harvested together and the pulmonary vasculature was
cleared of blood by gentle injection of 10 ml sterile sal-
ine into the right ventricle. The lungs were then blotted
dry of surface blood and weighed.
Lung tissues were placed in 50 mM potassium phos-
phate buffer (pH 6.0) with 0.5% hexadecyltrimethylam-
monium bromide and homogenized as previously
suggested [14]. The homogenate was sonicated on ice
and centrifuged for 30 min at 3,000 g, 4°C. An aliquot
(0.1 ml) of supernatant was added to 2.9 ml of 50 mM
potassium phosphate buffer (pH 6.0) containing 0.167
mg/ml of O-dianisidine and 0.0005% hydrogen peroxide.
The rate of change in absorbance at 460 nm was mea-
sured over 3 min. One unit of MPO activity was defined
as the amount of enzyme that reduces 1 μmole of per-
oxide per min and the data were expressed as units per
gram of lung tissue (Units/g tissue).
Processing of lung after exposure to bacteria
Animals were sacrificed by intraperitoneal injection of
ketamine (80 mg/kg) and xylazine (10 mg/kg) at 18
hours after E.coli intratracheal injection for comparison
of their bacterial clearance between different groups of
mice. The whole lung was excised and washed with 10
ml of sterile cold saline. The viable bacteria counts of
homogenized lung and blood were determined after an
18-hour culture at 37°C in TSB-agar plates. Data were
expressed as CFUs per milliliter.
Western immunoblots
Protein levels of IL-1b in tissue were measured by Wes-
tern immunoblotting. Tissues were homogenized in pro-
tein extract buffer (Sigma) and homogenized samples
(50 μg of protein each) were subjected to 12.5% SDS-
PAGE under reducing conditions. Proteins were trans-
ferred onto PVDF membranes (Millipore) by using a
Semi-Dry Electrophoretic system (Bio-Rad). The IL-1b
was identified by goat polyclonal antibodies (Santa Cruz
Biotechnology Inc., Santa Cruz, CA, USA). The mem-
branes were incubated with the secondary antibodies
(Biotinylated anti-rabbit and anti-goat IgG) (Perkin-
Elmer Life Science, Boston, USA) for 1 hr at room tem-
perature. Blots were developed by the ECL Western
blotting detection reagents (Perkin-Elmer).
Polymerase chain reaction (PCR) and quantification of
PCR products
Total RNA was isolated from cells using TRIZOL
reagent (Invitrogen, Life Technologies). Reverse tran-
scription-generated cDNA encoding KC, IL-1b, and
MIP-2 genes were amplified using PCR. The sequences
are 5’ CGTCTAGACTTTCTCCGTTACTTGG3’ (anti-
sense) for KC, 5’ GAACAAAGGCAAGGCTAACTGA3’
(sense) and 5’ AACATAACAACATCTGGGCAAT3’
(antisense) for MIP-2. 5’ CAGCACGAGGCTTTT
TTGTTG3’ (sense) and 5’ TGGTGTGTGACGTTCC-
CATT3’ (antisense) for IL-1b. Meanwhile, we designed
one pair of primer: 5’ GTGGGCCGCTCTAGG-
CACCA3’ (sense) and 5’ CGGTTGGCCTTAGGGTT-
CAG3’ (antisense) for b-actin gene as a control. To a
sterile 0.2 ml tube were added 1.5 μl of 10×Ex Taq™
buffer, 1.2 μl of dNTP mixture (2.5 mM each), 0.2 μl
each of the sense and antisense primers (0.5 mg/ml),
100 ng to 150 ng of the cDNA template and an appro-
priate amount of water to make a total volume of 15 μl.
After adding 0.075 μl of TaKaRa Ex Taq™ polymerase
(5 units/μl), amplification was performed using a ther-
mocycler (Bio-Rad): 5 min at 95°C before the first cycle,
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1 min for denaturation at 95°C, 1 min for annealing at
58°C, and 1 min 30 sec for extension at 72°C, then
finally 10 min at 72°C after the last cycle. We recorded
the electrophoresis by CCD camera and compared the
band intensity by Kodak Digital Science TM ID Image
Analysis Software (Eastman Kodak Company).
Bacterial killing activity of alveolar macrophages
Alveolar macrophages (AM) were harvested from adult
C3H/HeN and C3He/HeJ mice by bronchoalveolar
lavage (BAL) with Tris-buffered saline containing 0.25
mM EDTA and EGTA. AM were washed three times
with RPMI 1640 and counted using trypan blue. AM
were collected and resuspended in HBSS as 106 cells/ml.
After 5 min of preincubation, the cell suspension was
incubated with E. coli (108/ml) at 37°C for 1 h with
shaking. The cells were removed as the pellet after cen-
trifugation at 200 ×g for 10 min, and E.coli number in
the supernatant was counted [15].
Statistical Analysis
Values are expressed as means ± standard deviation of
the mean, and p < 0.05 is considered to be statistical
significance. Intergroup comparisons were made using
one-way ANOVA followed by Bonferroni correction.
Statistical analysis was performed on Prism software
(GraphPad). The photographs shown represent the
results obtained from at least three independent
experiments.
Results
Antibiotic pretreatment decreased E.coli pneumonia-
induced pulmonary neutrophils infiltration and LPS
supplementation restored it in C3H/HeN mice but not in
C3H/HeJ mice
To define the role of TLR4 on the inhibitory effect of
oral antibiotic pretreatment on E.coli pneumonia-
induced pulmonary neutrophils infiltration, we exam-
ined MPO activity of the lung tissue of C3H/HeJ mice.
Intratracheal E.coli injection induced a significant three-
fold increase of MPO activity in lung compared with
that of PBS group (184 ± 21 vs. 39 ± 8 Units/g tissue)
in C3H/HeN mice (Figure. 1). LPS treatment with E.coli
pneumonia did not change MPO activity of lung in
comparison with that E.coli injection group in C3H/
HeN mice. Antibiotic pretreatment with E.coli pneumo-
nia significantly decreased 28% of MPO activity in com-
parison with that of E.coli group (127 ± 23 vs. 179 ± 21
Units/g tissue) without antibiotic pretreatment in C3H/
HeN mice. LPS supplementation with antibiotic pre-
treatment significantly increased lung MPO activity by
25% in comparison to that of E.coli + commensal deple-
tion group (149 ± 21 vs. 127 ± 23 Units/g tissue) in
C3H/HeN mice (Figure. 1). E.coli pneumonia
significantly increased MPO activity in the lungs of
C3H/HeJ mice compared with that of PBS group (86 ±
18 vs. 31 ± 11 Units/g tissue). Furthermore, C3H/HeJ
mice demonstrated a significant 51% decrease of E.coli
pneumonia-induced lung MPO activity in comparison
with that of C3H/HeN mice. Antibiotic pretreatment
with or without LPS supplementation did not change E.
coli pneumonia-induced MPO activity of the lungs in
C3H/HeJ mice.
Antibiotic pretreatment decreased the bacterial killing
activity of alveolar macrophages and LPS
supplementation restored it in C3H/HeN mice but not in
C3H/HeJ mice
To further define the effect of oral antibiotic pretreat-
ment on lung defense against pneumonia, we harvested
alveolar macrophages from C3H/HeN and C3H/HeJ
mice and examined their bacterial killing activity.
Alveolar macrophages were harvested and cultured
with E.coli. Bacterial killing activity of macrophages
was determined by counting the E. coli number that
remained. Antibiotic pretreatment significantly
increased bacterial retention by alveolar macrophages
compared with that of macrophages from the control
group in C3H/HeN mice (2836 ± 370, vs. 1916 ± 250
CFU). LPS supplementation in oral antibiotic signifi-
cantly decreased 31% bacterial retention by alveolar
macrophages compared with that of macrophages from
the commensal depletion group in C3H/HeN mice.
Furthermore, C3H/HeJ mice demonstrated a significant
22% increase of bacterial retention in comparison with
that of C3H/HeN mice. Antibiotic pretreatment with
or without LPS supplementation did not change the
Figure 1 Commensal depletion decreased E.coli pneumonia-
induced MPO activity of lung and LPS supplementation
reversed it in C3H/HeN mice but not in C3H/HeJ mice (n = 6
per group). * p < 0.05.
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bacterial killing activity of alveolar macrophages from
C3H/HeJ mice (Figure 2). There is no significant dif-
ference in alveolar macrophages number harvested
between C3H/HeN mice and C3H/HeJ mice (data not
show).
Antibiotic pretreatment enhanced E.coli pneumonia-
induced bacterial counts in lung in C3H/HeN mice but
not in C3H/HeJ mice
To further define the role of TLR4 in the effect of
commensal microflora on lung immunity, we examined
bacterial growth in lung in C3H/HeJ mice after E.coli
intratracheal injection. Antibiotic pretreatment
increased E.coli-induced bacterial counts in lung (Fig-
ure 3) and LPS supplementation decreased them in
C3H/HeN mice. Also, intratracheal injection of E.coli
(1 × 109 cfu/mouse) significantly increased lung bac-
terial counts in C3H/HeJ mice compared with those of
PBS injection group. However, antibiotic pretreatment
with or without LPS supplementation did not change
E.coli pneumonia-induced bacterial counts in lung in
C3H/HeJ mice.
Antibiotic pretreatment decreased E.coli pneumonia-
induced NF-B activation of lung and LPS
supplementation restored it in C3H/HeN mice but not in
C3H/HeJ mice
To define the role of NF-B activation in the effect of
oral antibiotic pretreatment on lung immunity, we
examined the NF-B DNA binding activity of lung
after E.coli intratracheal injection. Commensal deple-
tion significantly decreased NF-B activation of lung
after E.coli pneumonia in C3H/HeN mice compared
with that of control group. LPS supplementation
increased the NF-B activation of lung in C3H/HeN
mice compared with that of commensal depletion
group (Figure 4). In contrast, antibiotic pretreatment
with or without LPS supplementation did not change
the NF-B DNA binding activity of lung in C3H/HeJ
mice compared with that of control group (Figure
4A).
Antibiotic pretreatment increased IL-1b protein as well as
IL-1b, KC, and MIP-2 mRNA expression in lung tissue and
LPS supplementation reversed them in C3H/HeN mice but
not in C3H/HeJ mice
IL-1b expression in lung plays an important role in the
inflammatory signaling, and its signaling pathway is cri-
tical to the activation of the pro-inflammatory response
of inflammatory cells [16]. We examined IL-1b protein
and IL-1b, KC, as well as MIP-2 mRNA expression in
the lungs in C3H/HeN mice as well as in C3H/HeJ
mice. In E.coli-treated C3H/HeN mice, antibiotic pre-
treatment significantly increased IL-1b protein (Figure
4B) and IL-1b, KC, as well as MIP-2 mRNA expression
(Figure 4C) in the lung compared with those without
pretreatment. LPS supplementation markedly decreased
E.coli pneumonia-induced IL-1b protein and IL-1b, KC,
as well as MIP-2 mRNA expression in the lung com-
pared with those of commensal depletion group in
C3H/HeN mice. However, antibiotic pretreatment with
or without LPS supplementation did not change IL-1b
KC, MIP2 protein and mRNA expression in the lung of
C3H/HeJ mice.
Figure 2 Commensal depletion (Comm. depl) decreased the
bacterial killing activity of alveolar macrophages and LPS
supplementation (Comm. depl + LPS) reversed it in C3H/HeN
but not in C3H/HeJ mice (n = 6 per group). * p < 0.05.
Figure 3 Antibiotic pretreatment enhanced E.coli pneumonia-
induced bacterial counts in lung in C3H/HeN mice but not in
C3H/HeJ mice. Antibiotic pretreatment increased E.coli-induced
bacterial counts in lung and LPS supplementation decreased them
in C3H/HeN mice. However, antibiotic pretreatment with or
without LPS supplementation did not change E.coli pneumonia-
induced bacterial counts in lung in C3H/HeJ mice (n = 6 per
group). * p < 0.05.
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Antibiotic pretreatment enhanced E.coli pneumonia-
induced mortality and LPS supplementation decreased it
in C3H/HeN mice
To further define the role of gut flora in the E.coli pneu-
monia-induced mortality, we examined the mortality in
C3H/HeN mice after antibiotic pretreatment with or
without LPS supplementation. E.coli intratracheal injec-
tion alone did not induce mortality in C3H/HeN mice.
Antibiotic pretreatment with subsequent E.coli intratra-
cheal injection induced a significant increase of mortal-
ity (70%) in C3H/HeN. LPS supplementation with
antibiotic pretreatment significantly decreased E.coli
pneumonia-induced mortality (38%) in C3H/HeN mice
(Figure 5). However, in E.coli-treated C3H/HeJ mice,
antibiotic pretreatment did not induce mortality.
Discussion
Commensal microflora in the gut are reported to be
important regulators for the intestinal haemostasis and
the intestinal innate immunity [8]. In the present study,
we further demonstrate that gut flora are critical in
enhancing lung inflammatory reaction against E.coli
pneumonia. MPO system plays an important role in the
microbicidal activity of neutrophils in the innate
immune response to infection [17]. However, an acute
innate immune phagocytes response to bacteria in the
lung has also been characterized by the infiltration of
neutrophils [18], thus, they are necessary for this pro-
cess. Our data clearly demonstrate that commensal
depletion decreases E.coli intratracheal injection-induced
MPO activity. This indicates that gut flora are important
in maintaining neutrophils infiltration in the lung while
bacteria invasion. LPS, a TLR4 ligand, supplementation
with oral antibiotic pretreatment reverses commensal
depletion-induced reduction of MPO activity, suggesting
that oral TLR4 stimulation increases neutrophils infiltra-
tion in the lung. Moreover, oral antibiotic treatment
with or without LPS supplementation does not change
Figure 4 Commensal depletion decreased NF-B DNA-binding
activity and increased IL-1b, KC, as well as MIP-2 expression in
the lung in C3H/HeN mice but not in C3H/HeJ (TLR4 mutant)
mice. (A) Commensal depletion (Comm. depl) decreased the NF-B
activation of lung after E.coli pneumonia and LPS supplementation
(Comm. depl + LPS) restored it in C3H/HeN mice but not in C3H/
HeJ mice (n = 5). * p < 0.05, vs. control group in C3H/HeN mice. (B)
Commensal depletion increased IL-1b protein expression in the
lung after E.coli pneumonia and LPS supplementation decreased
them in C3H/HeN mice but not in C3H/HeJ mice (n = 5). Signal
intensity was determined by densitometry and normalized to b-
actin. * p < 0.05, vs. control group in C3H/HeN mice. (C)
Commensal depletion increased IL-1b KC, and MIP-2 mRNA
expression in the lung after E.coli pneumonia and LPS
supplementation alleviated them in C3H/HeN mice but not in C3H/
HeJ (TLR4-/-) mice. Signal intensity was determined by densitometry
and normalized to b-actin. * p < 0.05, vs. E.coli control group.
Figure 5 Antibiotic pretreatment with subsequent E.coli
intratracheal injection induced an increase of mortality and
LPS supplementation decreased it in C3H/HeN mice. However,
in E.coli-treated C3H/HeJ mice, antibiotic pretreatment did not
induce mortality. * p < 0.05, vs. commensal depletion + E.coli group
(n = 15 per group).
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E.coli pneumonia-induced MPO activity in TLR4 mutant
mice. At last, E.coli pneumonia induces less MPO activ-
ity in TLR4 mutant mice than in WT mice. These sug-
gest that TLR4 signaling pathways are involved in E.coli
pneumonia-induces neutrophils infiltration in the lung.
Altogether, our data demonstrate that gut flora are
important in enhancing lung neutrophils infiltration
against E.coli pneumonia through TLR4 and depletion
of TLR4 decreases bacterial challenge-induced lung
inflammation.
Next, we try to clarify the effect of commensal deple-
tion on the innate immunity in the lung. Since alveolar
macrophages are pivotal to the phagocytic defense in
the lung [19], our results indicate that gut commensal
microflora are critical in maintaining the bacterial killing
activity of alveolar macrophages. First, commensal
depletion decreases the bacterial killing activity of alveo-
lar macrophages in WT mice and LPS supplementation
reverses its effect. Moreover, alveolar macrophages in
TLR4 mutant mice demonstrate a decrease of bacterial
killing activity compared with those in WT mice. Also,
commensal depletion with or without LPS supplementa-
tion does not change the bacterial killing activity of
alveolar macrophage in C3H/HeJ mice. This suggests
that effect of commensal depletion on the alveolar
macrophage is through TLR4. Together, our data indi-
cate that gut flora play an important role in maintaining
the bacterial killing activity of alveolar macrophages
through TLR4 and depletion of TLR4 decreases the bac-
terial killing activity of alveolar macrophages.
NF-B family members control transcriptional activity
of various promoters of proinflammatory cytokines, cell
surface receptors, transcription factors, and adhesion
molecules that are involved in inflammation such as
TNFa, ICAM, KC, and MIP-2 [20]. Previous studies
have shown that TLR4 stimulation could maintain
intestinal haemostasis through the NF-B activation of
the intestinal mucosa [8]. NF-B activation is an essen-
tial immediate early step in innate immune cells activa-
tion [21]. The inhibitory effect of oral antibiotic
pretreatment on NF-B DNA binding activity in the
lung further corroborates the important role that com-
mensal microflora play in inducing NF-B signaling in
the lung. Nuclear factor kappa B (NF-B) regulates the
transcription of a wide array of gene products that are
involved in the molecular pathobiology of the lung [22].
Three lung cell types, epithelial cells, macrophages and
neutrophils, have been shown to be involved in the gen-
eration of lung inflammation through signaling mechan-
isms that are dependent on activation of the NF-B
pathway [22]. Inflammatory signaling through the NF-
B pathway by airway epithelial cells critically regulates
the innate immune response to P. aeruginosa [11]. Our
present results further suggest that commensal
microflora in intestinal tract are critical in inducing the
NF-B activation and lung defense against E.coli pneu-
monia. Moreover, the abolition of the stimulatory effect
of LPS on pulmonary NF-B activation and bacterial
killing activity of alveolar macrophages in TLR4 mutant
mice further corroborates that gut flora are important in
enhancing NF-B activation in the lung through TLR4
and LPS supplementation enhances lung defense
through the TLR4 and NF-B signaling pathways.
Both polymicrobial sepsis and intratracheally lipopoly-
saccharide (LPS) injection can induce acute lung inflam-
mation with elevated IL-1b, KC, MIP-2 levels and MPO
activity of lung in mice [23]. Interleukin-1b (IL-1b) has
been shown to induce the expression of intercellular
adhesion molecule-1 (ICAM-1) on airway epithelial cells
and contributes to inflammatory responses [24]. Our
data demonstrate that commensal depletion decreases
MPO activity and NF-B activation but induces IL-1b,
KC, and MIP-2 expression of lung after E.coli pneumo-
nia. Previously, mice deficient in TLR4 demonstrated a
substantial delay in clearance of H. influenzae with
diminished IL-1b, IL-6, TNFa, MIP-a, and MIP-2 in
bronchoalveolar lavage [9]. Similarly, our present data
demonstrate that oral antibiotic pretreatment with E.coli
pneumonia-induced NF-B activation as well as IL-1b,
KC, and MIP-2 expression of lung are decreased in
C3H/HeJ mice. Altogether, our data suggest that com-
mensal microflora are critical in decreasing KC, MIP-2,
and IL-1b of lung in response to E.coli pneumonia.
More importantly, commensal depletion increases E.
coli pneumonia-induced mortality and LPS supplemen-
tation significantly decreases it in WT mice. This
further corroborates that gut commensal microflora is
critical in maintaining lung defense against bacterial
challenge through the increase of the bacterial killing
activity of alveolar macrophage and neutrophils infil-
tration. Our recent work have demonstrated that com-
mensal gut depletion by antibiotic pretreatment before
E.coli pneumonia challenge in WT mice induced a 15-
fold and a 3-fold increase in bacterial counts in blood
and lung, respectively, and a 30% increase of mortality
when compared with the E.coli group [25]. Our pre-
sent data further demonstrate that E.coli pneumonia
challenge induced a 30% decrease of MPO activity in
the lung and a significant decrease of bacterial killing
activity of alveolar macrophage in WT mice but not in
TLR4 deficient mice. Altogether, our data indicate that
commensal flora play an important role in maintaining
lung inflammation reaction against E.coli pneumonia
through TLR4. Our data also imply that early enteral
feeding to restore commensal microflora or adding
TLRs ligands in diet might be a feasible way to
increase host defense against pneumonia in intensive
care patients.
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Conclusions
From our present results, the mechanism by which
commensal microflora regulate E.coli pneumonia-
induced lung inflammatory reaction has been described.
Commensal microflora increase NF-B DNA binding
activity but decrease IL-1b, KC, as well as MIP-2 expres-
sion in the lung after E.coli pneumonia. Commensal
microflora also enhance neutrophils infiltration and the
killing activity of alveolar macrophage against E.coli
pneumonia through TLR4.
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